Acute Coronary Syndrome in Diabetic Patients

Sponsor
Faculty of Medicine, Tarumanagara University (Other)
Overall Status
Completed
CT.gov ID
NCT03607201
Collaborator
Cengkareng General Hospital (Other)
86
1
13
6.6

Study Details

Study Description

Brief Summary

This study aims to compare the clinical profile and outcomes of acute coronary syndrome patients with diabetes and without diabetes.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

Adult patients (≥ 18 years of age) with acute coronary syndrome which are diagnosed under International Classification of Disease (ICD-10) coding of I24.9 were included in this study. The inclusion criteria are patients with primary diagnosis of I24.9 and with a complete record of prior medical and treatment history, electrocardiographic findings, cardiac marker results and outcomes. Participants were grouped into 2 groups - diabetic and non-diabetic based on history of diabetes prior to ACS. Diagnosis of ACS was made based on clinical, electrocardiographic and cardiac marker findings found in the medical record.

Data such as age, sex, ethnic, education, prior medical and treatment history, electrocardiographic and cardiac enzyme results as well as outcomes were collected from the patients' medical records. Outcomes of interest were defined as either concomitant heart failure, acute lung edema, malignant arrhythmia, mortality or combinations of them as diagnosed in the medical records. Heart failure is defined based on echocardiographic findings from the medical records. Acute Lung Edema is defined based on medical records or reported clinical findings of lung edema - rhonchi reported in 1/3 of the lungs with oxygen saturation <90%. Whereas malignant arrhythmia is defined as the presence of ventricular tachycardia (VT) or ventricular fibrillation (VF).

Study Design

Study Type:
Observational
Actual Enrollment :
86 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Comparing Clinical Profile and Outcomes of Acute Coronary Syndrome in Diabetic and Non-Diabetic Patients
Actual Study Start Date :
Aug 1, 2017
Actual Primary Completion Date :
Jun 30, 2018
Actual Study Completion Date :
Aug 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Diabetic

History of diabetes prior to Acute Coronary Syndrome

Other: No intervention
Routine care

Non-diabetic

No documented history of diabetes prior to Acute Coronary Syndrome

Other: No intervention
Routine care

Outcome Measures

Primary Outcome Measures

  1. Heart Failure [Through study completion, an average of 1 year]

    Based on echocardiographic findings from the medical records

  2. Malignant Arrhythmia [Through study completion, an average of 1 year]

    Presence of ventricular tachycardia (VT) or ventricular fibrillation (VF)

  3. Acute Lung Edema [Through study completion, an average of 1 year]

    Based on medical records or reported clinical findings of lung edema - rhonchi reported in 1/3 of the lungs with oxygen saturation <90%.

  4. Cardiogenic Shock [Through study completion, an average of 1 year]

    Clinical Diagnosis of Cardiogenic Shock reported in medical records

  5. Recurrent Myocardial Infarction [Through study completion, an average of 1 year]

    Clinical Diagnosis of Recurrent Myocardial Infarction reported in medical records

  6. Mortality [Through study completion, an average of 1 year]

    Patient death reported in medical records

Other Outcome Measures

  1. GRACE Score [Through study completion, an average of 1 year]

    GRACE (Global Registry of Acute Coronary Events) mortality risk score

  2. TIMI Score [Through study completion, an average of 1 year]

    Thrombolysis In Myocardial Infarction (TIMI) mortality risk score

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of Acute Coronary Syndrome

  • Presence of detail on diabetes history

Exclusion Criteria:
  • Unavailability of electrocardiographic findings, cardiac marker results

  • Incomplete records of prior medical and treatment history

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cengkareng General Hospital Jakarta DKI Jakarta Indonesia

Sponsors and Collaborators

  • Faculty of Medicine, Tarumanagara University
  • Cengkareng General Hospital

Investigators

  • Principal Investigator: Anthony P Sunjaya, Faculty of Medicine, Tarumanagara University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anthony Paulo Sunjaya, Principal Investigator, Faculty of Medicine, Tarumanagara University
ClinicalTrials.gov Identifier:
NCT03607201
Other Study ID Numbers:
  • APS006
First Posted:
Jul 31, 2018
Last Update Posted:
Oct 16, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Anthony Paulo Sunjaya, Principal Investigator, Faculty of Medicine, Tarumanagara University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 16, 2018